Advertisement

Prediction of Drug Response with a Topology Based Dual-Layer Network Model

  • Suyun Huang
  • Xing-Ming ZhaoEmail author
Conference paper
Part of the Lecture Notes in Computer Science book series (LNCS, volume 10847)

Abstract

Identifying the response of a cancer patient to a particular therapeutic agent is critical in drug discovery and will significantly facilitate the development of personalized medicine. The publicly available drug response profiles across cell lines provide an alternative way for predicting the response of cancer drugs. In this work, we propose a topology based dual-layer network (TDLN) model to predict drug response based on large-scale cell line experiments. With the Cancer Cell Line Encyclopedia (CCLE), Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Therapeutic Response Portal (CTRP) datasets as benchmark datasets, our proposed topology based dual-layer network model outperforms other existing popular approaches and identify some novel indications of known drugs for cancer.

Keywords

Drug responses Large-scale data Dual-layer network model Novel indications 

Notes

Acknowledgments

This work was partly supported by National Natural Science Foundation of China (61772368, 61572363, 91530321, 61602347) and Natural Science Foundation of Shanghai (17ZR1445600).

References

  1. 1.
    Costello, J.C., et al.: A community effort to assess and improve drug sensitivity prediction algorithms. Nat. Biotechnol. 32, 1202–1212 (2014)CrossRefGoogle Scholar
  2. 2.
    Mirnezami, R., et al.: Preparing for precision medicine. N. Engl. J. Med. 366, 489–491 (2012)CrossRefGoogle Scholar
  3. 3.
    Simon, R., Roychowdhury, S.: Implementing personalized cancer genomics in clinical trials. Nat. Rev. Drug Discov. 12, 358–369 (2013)CrossRefGoogle Scholar
  4. 4.
    Wistuba, I.I., et al.: Methodological and practical challenges for personalized cancer therapies. Nat. Rev. Clin. Oncol. 8, 135–141 (2011)CrossRefGoogle Scholar
  5. 5.
    Qin, G., Zhao, X.M.: A survey on computational approaches to identifying disease biomarkers based on molecular networks. J. Theoret. Biol. 362, 9–16 (2014)CrossRefGoogle Scholar
  6. 6.
    Zeng, T., et al.: Big-data-based edge biomarkers: study on dynamical drug sensitivity and resistance in individuals. Brief. Bioinform. 17, 576–592 (2016)CrossRefGoogle Scholar
  7. 7.
    Barretina, J., et al.: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603–607 (2012)CrossRefGoogle Scholar
  8. 8.
    Garnett, M.J., et al.: Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570–575 (2012)CrossRefGoogle Scholar
  9. 9.
    Rees, M.G., et al.: Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat. Chem. Biol. 12, 109–116 (2016)CrossRefGoogle Scholar
  10. 10.
    Cui, J., et al.: An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res. 39, 1197–1207 (2011)CrossRefGoogle Scholar
  11. 11.
    Li, Z., et al.: Two-stage flux balance analysis of metabolic networks for drug target identification. BMC Syst. Biol. 5(Suppl 1), S11 (2011)MathSciNetCrossRefGoogle Scholar
  12. 12.
    Liu, X., et al.: Identifying disease genes and module biomarkers by differential interactions. J. Am. Med. Inf. Assoc. 19, 241–248 (2012)CrossRefGoogle Scholar
  13. 13.
    Menden, M.P., et al.: Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties. PLoS ONE 8, e61318 (2013)CrossRefGoogle Scholar
  14. 14.
    Zeng, T., et al.: Prediction of dynamical drug sensitivity and resistance by module network rewiring-analysis based on transcriptional profiling. Drug Resist. Updat. 17, 64–76 (2014)CrossRefGoogle Scholar
  15. 15.
    Zhang, N., et al.: Predicting anticancer drug responses using a dual-layer integrated cell line-drug network model. PLoS Comput. Biol. 11, e1004498 (2015)CrossRefGoogle Scholar
  16. 16.
    Wang, Y., et al.: PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 37, W623–W633 (2009)CrossRefGoogle Scholar
  17. 17.
    Yap, C.W.: PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J. Comput. Chem. 32, 1466–1474 (2011)CrossRefGoogle Scholar
  18. 18.
    Cheng, F., et al.: Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol. 8, e1002503 (2012)CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Computer ScienceTongji UniversityShanghaiChina
  2. 2.Institute of Science and Technology for Brain-Inspired IntelligenceFudan UniversityShanghaiChina

Personalised recommendations